This Top Warren Buffett Stock Is Making a Game-Changing Deal

Occidental Petroleum is selling its OxyChem subsidiary to Berkshire Hathaway for $9.7 billion, primarily to repay $6.5 billion of debt and reduce its principal debt below $15 billion. This strategic divestiture will enhance Occidental's financial flexibility, save over $350 million annually in interest expenses, and sharpen its focus on its core oil and gas business, positioning it as a financially stronger and lower-risk energy company. Berkshire Hathaway, in turn, acquires a consistently profitable chemical enterprise with significant growth potential.

Analysis

Occidental Petroleum (OXY) is executing a significant strategic deleveraging by divesting its OxyChem subsidiary to Berkshire Hathaway for $9.7 billion in cash. This transaction is primarily aimed at fortifying OXY's balance sheet, with the company allocating $6.5 billion of the proceeds to debt repayment to finally achieve its long-standing target of reducing principal debt below $15 billion. This substantially de-risks the company's financial profile, a persistent concern following the debt-heavy Anadarko acquisition in 2019. The immediate financial benefits are material, including an estimated annual interest expense reduction of over $350 million, which will directly bolster free cash flow. Strategically, the sale transforms Occidental into a more focused pure-play oil and gas production company, freeing management to concentrate on what CEO Vicki Hollub describes as a "20+ years of low-cost resource runway." For Berkshire Hathaway, which already owns nearly 27% of OXY, the acquisition adds a consistently profitable chemical business poised to deliver an incremental $325 million in annualized EBITDA by 2026, fitting its model of acquiring stable, cash-generative assets.

Key Decisions for Investors

• Investors should re-evaluate Occidental Petroleum as a de-risked, financially stronger pure-play E&P entity, where the improved balance sheet and enhanced free cash flow could accelerate capital returns via share repurchases and dividend growth.
• Consider that while the divestiture resolves a major debt overhang, it also removes the stable, counter-cyclical cash flows from the OxyChem segment, increasing the company's direct earnings sensitivity to oil and gas price volatility.
• The transaction serves as a strong signal of Berkshire Hathaway's confidence in OXY's core upstream assets and management, which long-term investors may view as a validation of the underlying value proposition even after the sale of a profitable subsidiary.
• Monitor Occidental's capital allocation discipline post-transaction, specifically its ability to generate value from its focused E&P assets and the pace at which it resumes the redemption of Berkshire's high-cost preferred equity, which is slated to begin after August 2029.